Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,42 USD | 0,00% | -5,79% | -20,28% |
03/04 | SUTRO BIOPHARMA, INC. : Piper Sandler mantiene la raccomandazione Buy | ZM |
03/04 | SUTRO BIOPHARMA, INC. : Truist Securities rimane Buy | ZM |
Attività
Numero di dipendenti: 302
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 68 | 100,0 % | 154 | 100,0 % | +126,84% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
William Newell
CEO | Chief Executive Officer | 66 | 14/01/09 |
Jane Chung
PSD | President | 53 | 09/08/21 |
Edward Albini
DFI | Director of Finance/CFO | 66 | 31/01/13 |
Steve Michel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Berman
CTO | Chief Tech/Sci/R&D Officer | - | 21/05/20 |
Chief Tech/Sci/R&D Officer | - | 18/09/23 | |
Henry Heinsohn
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anne Borgman
CTO | Chief Tech/Sci/R&D Officer | 56 | 28/02/23 |
Public Communications Contact | 67 | 01/01/08 | |
Werner Rubas
PRN | Corporate Officer/Principal | - | 16/09/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 24/06/19 |
James Panek
BRD | Director/Board Member | 71 | 07/01/20 |
Daniel Petree
BRD | Director/Board Member | 68 | - |
John Freund
BRD | Director/Board Member | 70 | 01/02/14 |
Joseph Lobacki
BRD | Director/Board Member | 65 | 01/02/17 |
William Newell
CEO | Chief Executive Officer | 66 | 14/01/09 |
Michael Dybbs
BRD | Director/Board Member | 49 | 25/07/18 |
Heidi Hunter
BRD | Director/Board Member | 66 | 19/11/21 |
Jon Wigginton
BRD | Director/Board Member | 62 | 30/11/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 75 488 593 | 74 756 129 ( 99,03 %) | 0 | 99,03 % |
Coordinate società
Sutro Biopharma, Inc.
111 Oyster Point Boulevard
94080, South San Francisco
+650 881 6500
http://www.sutrobio.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-20,28% | 280 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,73 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione STRO
- Società Sutro Biopharma, Inc.